{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:39Z","timestamp":1792097379741,"version":"4.4.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurochemistry International"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1016\/j.neuint.2012.07.015","type":"journal-article","created":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T22:34:05Z","timestamp":1343255645000},"page":"866-873","source":"Crossref","is-referenced-by-count":15,"title":["Reversal of BoNT\/A-mediated inhibition of muscle paralysis by 3,4-diaminopyridine and roscovitine in mouse phrenic nerve-hemidiaphragm preparations"],"prefix":"10.1016","volume":"61","author":[{"given":"Michael","family":"Adler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharad S.","family":"Deshpande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P.","family":"Apland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Borrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuint.2012.07.015_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/S0041-0101(99)00231-7","article-title":"Antagonism of botulinum toxin A-mediated muscle paralysis by 3,4-diaminopyridine delivered via osmotic minipumps","volume":"38","author":"Adler","year":"2000","journal-title":"Toxicon"},{"key":"10.1016\/j.neuint.2012.07.015_b0010","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0041-0101(95)00127-1","article-title":"Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin","volume":"34","author":"Adler","year":"1996","journal-title":"Toxicon"},{"key":"10.1016\/j.neuint.2012.07.015_b0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1504\/TBJ.2008.026469","article-title":"Evaluation of toosendanin as a botulinum neurotoxin antagonist","volume":"1","author":"Adler","year":"2008","journal-title":"The Botulinum J."},{"key":"10.1016\/j.neuint.2012.07.015_b0020","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1085\/jgp.74.1.129","article-title":"Reaction of tetraethylammonium with the open and closed conformation of the acetylcholine receptor ionic channel complex","volume":"74","author":"Adler","year":"1979","journal-title":"J. Gen. Physiol."},{"key":"10.1016\/j.neuint.2012.07.015_b0025","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0041-0101(94)00183-9","article-title":"Antagonism of botulinum toxin-induced muscle weakness by 3,4-diaminopyridine in rat phrenic nerve-hemidiaphragm preparations","volume":"33","author":"Adler","year":"1995","journal-title":"Toxicon"},{"key":"10.1016\/j.neuint.2012.07.015_b0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/0022-510X(94)00225-D","article-title":"3,4-Diaminopyridine as a treatment for amyotrophic lateral sclerosis","volume":"129","author":"Aisen","year":"1995","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuint.2012.07.015_b0035","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1517\/13543780903418445","article-title":"Seliciclib in malignancies","volume":"18","author":"Aldoss","year":"2009","journal-title":"Expert Opin. Invest. Drugs"},{"key":"10.1016\/j.neuint.2012.07.015_b0040","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jama.285.8.1059","article-title":"Botulinum toxin as a biological weapon: medical and public health management","volume":"285","author":"Arnon","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.neuint.2012.07.015_b0045","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.bjc.6603509","article-title":"A phase I trial of the selective oral cyclin-dependent kinase inhibitor seliciclib (CYC202; R-Roscovitine), administered twice daily for 7 days every 21 days","volume":"96","author":"Benson","year":"2007","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.neuint.2012.07.015_b0050","doi-asserted-by":"crossref","first-page":"34015","DOI":"10.1074\/jbc.M111.272054","article-title":"Unique ganglioside recognition strategies for clostridial neurotoxins","volume":"286","author":"Benson","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2012.07.015_b0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/ana.410270411","article-title":"Preliminary trial of 3,4-diaminopyridine in patients with multiple sclerosis","volume":"27","author":"Bever","year":"1990","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuint.2012.07.015_b0060","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1529\/biophysj.104.052837","article-title":"Slowed N-type calcium channel (CaV2.2) deactivation by the cyclin-dependent kinase inhibitor roscovitine","volume":"89","author":"Buraei","year":"2005","journal-title":"Biophys. J."},{"key":"10.1016\/j.neuint.2012.07.015_b0065","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.neuropharm.2006.10.006","article-title":"Roscovitine differentially affects CaV2 and Kv channels by binding to the open state","volume":"52","author":"Buraei","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuint.2012.07.015_b0070","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1056\/NEJM196804252781704","article-title":"Botulism and guanidine","volume":"278","author":"Cherington","year":"1968","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.neuint.2012.07.015_b0075","doi-asserted-by":"crossref","first-page":"19","DOI":"10.3109\/15563657708989815","article-title":"Effect of guanidine, germine and steroids in a case of botulism","volume":"11","author":"Cherington","year":"1977","journal-title":"Clin. Toxicol."},{"key":"10.1016\/j.neuint.2012.07.015_b0080","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0006-291X(72)90350-6","article-title":"A common subunit structure in Clostridium botulinum type A, B and E toxins","volume":"48","author":"DasGupta","year":"1972","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuint.2012.07.015_b0085","first-page":"379","article-title":"Human type A botulism and treatment with 3,4-diaminopyridine","volume":"32","author":"Davis","year":"1992","journal-title":"Electromyogr. Clin. Neurophysiol."},{"key":"10.1016\/j.neuint.2012.07.015_b0090","doi-asserted-by":"crossref","first-page":"9380","DOI":"10.1523\/JNEUROSCI.5092-06.2007","article-title":"Differential abilities of SNAP-25 homologs to support neuronal function","volume":"27","author":"Delgado-Mart\u00ednez","year":"2007","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuint.2012.07.015_b0095","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.neuroscience.2010.02.041","article-title":"(R)-roscovitine prolongs the mean open time of unitary N-type calcium channel currents","volume":"167","author":"DeStefino","year":"2010","journal-title":"Neuroscience"},{"key":"10.1016\/j.neuint.2012.07.015_b0100","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1126\/science.1123654","article-title":"SV2 is the protein receptor for botulinum neurotoxin A","volume":"312","author":"Dong","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.neuint.2012.07.015_b0105","doi-asserted-by":"crossref","first-page":"29604","DOI":"10.1074\/jbc.M703619200","article-title":"Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes","volume":"282","author":"Fischer","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neuint.2012.07.015_b0110","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1126\/science.1214270","article-title":"Botulinum neurotoxin is shielded by NTNHA in an interlocked complex","volume":"335","author":"Gu","year":"2012","journal-title":"Science"},{"key":"10.1016\/j.neuint.2012.07.015_b0115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-6405-7-7","article-title":"Inhibition of human immunodeficiency virus type-1 by cdk inhibitors","volume":"7","author":"Guendel","year":"2010","journal-title":"Aids Res. Ther."},{"key":"10.1016\/j.neuint.2012.07.015_b0120","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/infdis\/150.3.407","article-title":"Antitoxin levels in botulism patients treated with trivalent equine botulism antitoxin to toxin types A, B, and E","volume":"150","author":"Hatheway","year":"1984","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.neuint.2012.07.015_b0125","doi-asserted-by":"crossref","first-page":"229","DOI":"10.2147\/NDT.S10469","article-title":"Impact of extended-release dalfampridine on walking ability in patients with multiple sclerosis","volume":"7","author":"Hayes","year":"2011","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.neuint.2012.07.015_b0130","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1113\/jphysiol.1991.sp018421","article-title":"On the active form of 4-aminopyridine: block of K+ currents in rabbit Schwann cells","volume":"433","author":"Howe","year":"1991","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.neuint.2012.07.015_b0135","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1124\/mol.111.074989","article-title":"Elucidating the molecular basis of action of a classic drug: guanidine compounds as inhibitors of voltage gated potassium channels","volume":"80","author":"Kalia","year":"2011","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.neuint.2012.07.015_b0140","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/WNO.0b013e3182258086","article-title":"Comparison of 10-mg doses of 4-aminopyridine and 3,4-diaminopyridine for the treatment of downbeat nystagmus","volume":"31","author":"Kalla","year":"2011","journal-title":"J. Neuroophthalmol."},{"key":"10.1016\/j.neuint.2012.07.015_b0145","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1345\/aph.1L028","article-title":"Sustained-release fampridine for symptomatic treatment of multiple sclerosis","volume":"42","author":"Korenke","year":"2008","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neuint.2012.07.015_b0150","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/nsb879","article-title":"Translocation of botulinum neurotoxin light chain protease through the heavy chain channel","volume":"10","author":"Koriazova","year":"2003","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.neuint.2012.07.015_b0155","doi-asserted-by":"crossref","first-page":"14316","DOI":"10.1021\/bi701564f","article-title":"Comparative role of neurotoxin-associated proteins in the structural stability and endopeptidase activity of botulinum neurotoxin complex types A and E","volume":"46","author":"Kukreja","year":"2007","journal-title":"Biochemistry"},{"key":"10.1016\/j.neuint.2012.07.015_b0160","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1016\/j.ejca.2010.08.001","article-title":"Phase I evaluation of seliciclib (R-roscovitine), a novel oral cyclin-dependent kinase inhibitor, in patients with advanced malignancies","volume":"46","author":"Le Tourneau","year":"2010","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.neuint.2012.07.015_b0165","doi-asserted-by":"crossref","first-page":"202","DOI":"10.3390\/molecules16010202","article-title":"Small molecule inhibitors as countermeasures for botulinum intoxication","volume":"16","author":"Li","year":"2010","journal-title":"Molecules"},{"key":"10.1016\/j.neuint.2012.07.015_b0170","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1111\/j.1460-9568.1997.tb01431.x","article-title":"Multiple types of Ca2+ channels in mouse motor nerve terminals","volume":"9","author":"Lin","year":"1997","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuint.2012.07.015_b0175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1128\/CMR.19.2.298-314.2006","article-title":"Laboratory diagnostics of botulism","volume":"19","author":"Lindstr\u00f6m","year":"2006","journal-title":"Clin. Microbiol. Rev."},{"key":"10.1016\/j.neuint.2012.07.015_b0180","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0022-510X(77)90037-5","article-title":"Antagonism of the paralysis produced by botulinum toxin in the rat. The effects of tetraethylammonium, guanidine and 4-aminopyridine","volume":"32","author":"Lundh","year":"1977","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuint.2012.07.015_b0185","doi-asserted-by":"crossref","unstructured":"Marcus, S.M., 2009. Reflections on the care of a patient severely poisoned by \u2018rogue\u2019 botulinum toxin and rendered paralysed for a protracted hospital stay. The Botululinum J. 1, 318\u2013339.","DOI":"10.1504\/TBJ.2009.031683"},{"key":"10.1016\/j.neuint.2012.07.015_b0190","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1021\/cb1002366","article-title":"Symptomatic relief of botulinum neurotoxin\/A intoxication with aminopyridines: a new twist on an old molecule","volume":"5","author":"Mayorov","year":"2010","journal-title":"ACS Chem. Biol."},{"key":"10.1016\/j.neuint.2012.07.015_b0195","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/mus.880100514","article-title":"Aminoglycosides and 3,4-diaminopyridine on neuromuscular block cause by botulinum type A toxin","volume":"10","author":"Molg\u00f3","year":"1987","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neuint.2012.07.015_b0200","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-2999(80)90378-7","article-title":"Potency of 3,4-diaminopyridine and 4-aminopyridine on mammalian neuromuscular transmission and the effect of pH changes","volume":"61","author":"Molg\u00f3","year":"1980","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.neuint.2012.07.015_b0205","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.tibs.2005.05.002","article-title":"SNARE complexes and neuroexocytosis: how many, how close?","volume":"30","author":"Montecucco","year":"2005","journal-title":"Trends Biochem."},{"key":"10.1016\/j.neuint.2012.07.015_b0210","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0301-4622(02)00002-9","article-title":"The nature of the receptor site for the reversible K+ channel blocking by aminopyridines","volume":"96","author":"Mu\u00f1oz-Caro","year":"2002","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.neuint.2012.07.015_b0215","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1113\/jphysiol.2007.128702","article-title":"Developmental changes in potassium currents at the rat calyx of Held presynaptic terminal","volume":"581","author":"Nakamura","year":"2007","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.neuint.2012.07.015_b0220","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1469-7793.1997.623bj.x","article-title":"Rythmic bursting of pre- and post-inspiratory neurons during central apnoea in mature mice","volume":"502","author":"Paton","year":"1997","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.neuint.2012.07.015_b0225","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/BF00586682","article-title":"Two different presynaptic calcium currents in mouse motor nerve terminals","volume":"406","author":"Penner","year":"1986","journal-title":"Pflugers Arch."},{"key":"10.1016\/j.neuint.2012.07.015_b0230","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1001\/jama.1978.03290210058027","article-title":"Botulism and guanidine. Ten years later","volume":"240","author":"Puggiari","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/j.neuint.2012.07.015_b0235","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1017\/S1049023X00008062","article-title":"Single-breath count test: an important adjunct in the triaging of patients in a mass-casualty incident due to botulism","volume":"25","author":"Rega","year":"2010","journal-title":"Prehospital Disaster Med."},{"key":"10.1016\/j.neuint.2012.07.015_b0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1345\/aph.1C034","article-title":"Management of botulism","volume":"37","author":"Robinson","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.neuint.2012.07.015_b0245","doi-asserted-by":"crossref","first-page":"207","DOI":"10.3390\/toxins3030207","article-title":"Post-intoxication inhibition of botulinum neurotoxin serotype A within neurons by small-molecule, non-peptidic inhibitors","volume":"3","author":"Ruthel","year":"2011","journal-title":"Toxins"},{"key":"10.1016\/j.neuint.2012.07.015_b0250","doi-asserted-by":"crossref","first-page":"221","DOI":"10.7326\/0003-4819-129-3-199808010-00011","article-title":"Botulism in the United States: a clinical and epidemiological review","volume":"129","author":"Shapiro","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.neuint.2012.07.015_b0255","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s12264-011-1048-y","article-title":"Potassium blockers as an effective treatment to restore impulse conduction in injured axons","volume":"27","author":"Shi","year":"2011","journal-title":"Neurosci. Bull."},{"key":"10.1016\/j.neuint.2012.07.015_b0260","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1146\/annurev.pharmtox.44.101802.121554","article-title":"Identification of the major steps in botulinum toxin action","volume":"44","author":"Simpson","year":"2004","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.neuint.2012.07.015_b0265","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1128\/IAI.52.3.858-862.1986","article-title":"A preclinical evaluation of aminopyridines as putative therapeutic agents in the treatment of botulism","volume":"52","author":"Simpson","year":"1986","journal-title":"Infect. Immun."},{"key":"10.1016\/j.neuint.2012.07.015_b0270","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/444507","article-title":"Botulism","volume":"41","author":"Sobel","year":"2005","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.neuint.2012.07.015_b0275","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/0002-9343(84)90988-4","article-title":"Equine antitoxin use and other factors that predict outcome in type A foodborne botulism","volume":"76","author":"Tacket","year":"1984","journal-title":"Am. J. Med."},{"key":"10.1016\/j.neuint.2012.07.015_b0280","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1113\/expphysiol.1989.sp003329","article-title":"Botulinal neurotoxins as tools in studies of synaptic mechanisms","volume":"74","author":"Thesleff","year":"1989","journal-title":"Quart. J. Exp. Physiol."},{"key":"10.1016\/j.neuint.2012.07.015_b0285","doi-asserted-by":"crossref","unstructured":"Tsai, Y.C., Maditz, R., Kuo, C.-L., Fishman, P.S., Shoemaker, C.B., Oyler, G.A., Weissman, A.M., 2010. Targeting botulinum neurotoxin persistence by the ubiquitin-proteosome system. Proc. Natl. Acad. Sci. USA 107, 16554\u201316559.","DOI":"10.1073\/pnas.1008302107"},{"key":"10.1016\/j.neuint.2012.07.015_b0305","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.clinthera.2009.10.007","article-title":"Steady-state pharamacokinetics and tolerability of orally administered fampridine sustained-release 10-mg tablets in patients with multiple sclerosis: a 2-week, open label, follow-up study","volume":"31","author":"Vollmer","year":"2009","journal-title":"Clin. Ther."},{"key":"10.1016\/j.neuint.2012.07.015_b0295","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1113\/jphysiol.2001.013376","article-title":"Roscovitine: a novel regulator of P\/Q-type calcium channels and transmitter release in central neurons","volume":"540","author":"Yan","year":"2002","journal-title":"J. Physiol. (Lond.)"},{"key":"10.1016\/j.neuint.2012.07.015_b0300","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1124\/jpet.111.187104","article-title":"Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed state inactivation","volume":"340","author":"Yarotsky","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Neurochemistry International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018612002355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0197018612002355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T12:33:24Z","timestamp":1594470804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0197018612002355"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":60,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S0197018612002355"],"URL":"https:\/\/doi.org\/10.1016\/j.neuint.2012.07.015","relation":{},"ISSN":["0197-0186"],"issn-type":[{"value":"0197-0186","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]}}}